DexCom Inc. is a medical device company that specializes in continuous glucose monitoring systems for diabetes patients. Its success can be attributed to the effectiveness of its products, but also to the guidance and leadership provided by its board of directors. In this article, we will introduce you to the members of the DexCom board of directors, highlight their achievements and strengths, and discuss their vision for the company.
The current members of the DexCom board of directors are Kevin Sayer (CEO), Steven R. Altman, Richard Collins, Terrance H. Gregg, Karen Dahut, Mark A. Deutch, Barbara J. Dunn, Eric Topol, and Jay S. Skyler.
Each of these members brings unique experience and expertise to the board. Kevin Sayer, for example, has an extensive background in finance and management. Steven R. Altman has experience in law and intellectual property, while Terrance H. Gregg has experience in medical devices and biotechnology. Karen Dahut has a background in government contracting and cybersecurity, while Mark A. Deutch has experience in finance and accounting. Barbara J. Dunn has experience in marketing and communications, while Eric Topol is a world-renowned expert in cardiology. Jay S. Skyler has experience in clinical research and diabetes technology.
It is worth noting that the DexCom board of directors is committed to advancing diabetes care and improving the lives of people with diabetes. The company's mission is to empower people to take control of their diabetes through innovative technology and continuous glucose monitoring. The board of directors plays a crucial role in guiding the company towards achieving this mission, and each member brings a unique perspective and skillset to the table.
DexCom was founded in 1999 by Scott K. Glenn and John F. Burd. The company’s first product, the DexCom STS Continuous Glucose Monitoring System, received FDA approval in 2006. Steven Altman joined the board in 2001, while Richard Collins and Terrance Gregg joined in 2002 and 2003, respectively.
The board of directors has since evolved to include a diverse set of individuals with varied backgrounds and expertise in relevant fields. With the expansion of DexCom’s product offerings and the increasing importance of continuous glucose monitoring technology, the board has taken on a greater role in shaping the company’s vision and strategy.
In recent years, DexCom has made significant strides in the development of new continuous glucose monitoring products, including the DexCom G6 and the DexCom Share system. These products have revolutionized the way individuals with diabetes manage their condition, providing real-time glucose readings and alerts to help prevent dangerous highs and lows. The board of directors has played a crucial role in guiding the company’s research and development efforts, ensuring that DexCom remains at the forefront of continuous glucose monitoring technology.
The board of directors plays a crucial role in determining the strategic direction of DexCom. It is responsible for overseeing the company’s management, making key decisions regarding corporate governance, and ensuring that the interests of shareholders are protected. The board also identifies potential risks and opportunities for the company and works to mitigate risks while maximizing opportunities.
One of the key responsibilities of the board of directors is to ensure that DexCom is in compliance with all relevant laws and regulations. This includes financial reporting requirements, environmental regulations, and labor laws. The board works closely with the company’s management team to ensure that all policies and procedures are in place to meet these obligations.
In addition to its oversight role, the board of directors also plays an important role in shaping the company’s culture and values. It sets the tone for ethical behavior and ensures that the company operates with integrity in all of its dealings. The board also works to promote diversity and inclusion within the company, recognizing that a diverse workforce is essential to DexCom’s success.
The members of the DexCom board of directors have varying leadership styles, but all are dedicated to making informed and strategic decisions on behalf of the company. Some members, such as Terrance Gregg and Eric Topol, have a reputation for being innovative and risk-taking, while others, like Karen Dahut and Richard Collins, are known for their strategic thinking and attention to detail.
In addition to their individual leadership styles, the board members of DexCom also bring a diverse range of experiences and backgrounds to the table. For example, Jay Skyler is a renowned endocrinologist and diabetes researcher, while Barbara Kahn is a marketing expert with extensive experience in the healthcare industry.
Despite their differences, the board members of DexCom share a common goal of advancing the company's mission to improve the lives of people with diabetes. They work collaboratively to ensure that DexCom remains at the forefront of innovation in the field of continuous glucose monitoring, while also maintaining a strong focus on financial performance and long-term growth.
One of the key factors that makes the DexCom board of directors unique is the diversity of its members. The board includes individuals from different backgrounds, with different areas of expertise, and different perspectives. This diversity of thought leads to more creative problem-solving and better decision-making. Additionally, the board is committed to a culture of transparency, accountability, and ethical behavior.
Another aspect that sets the DexCom board of directors apart is their focus on innovation. The board is constantly seeking new and innovative ways to improve the company's products and services, as well as its overall operations. This commitment to innovation has helped DexCom stay ahead of the curve in the highly competitive medical technology industry.
Furthermore, the board of directors at DexCom is known for its strong leadership and strategic vision. They have a clear understanding of the company's goals and objectives, and work collaboratively to ensure that these are achieved. This has helped DexCom maintain its position as a leader in the field of continuous glucose monitoring, and has contributed to the company's overall success.
The board of directors shapes the corporate strategy and culture of DexCom by setting clear goals and objectives, and by providing oversight to management. The board works closely with the executive team to identify areas of opportunity and potential risks. It also ensures that DexCom’s values are reflected in its practices, policies, and culture. This includes a commitment to innovation, data-driven decision-making, and a focus on the patient experience.
One way the board of directors influences DexCom's corporate strategy is by staying up-to-date on industry trends and advancements. This allows them to make informed decisions about where to invest resources and how to position the company for future success. Additionally, the board regularly evaluates the performance of the executive team and provides feedback to help them improve and grow in their roles.
Another important role of the board is to ensure that DexCom is operating in an ethical and socially responsible manner. This includes monitoring the company's environmental impact, promoting diversity and inclusion, and upholding high standards of corporate governance. By prioritizing these values, the board helps to build trust and credibility with stakeholders, and positions DexCom as a leader in the healthcare industry.
DexCom’s board of directors is committed to strong corporate governance practices. This includes regular evaluations of the board’s performance, ensuring that the company’s compensation practices are fair and reasonable, and maintaining strong relationships with stakeholders. The board also keeps up to date with changing regulations and industry trends to ensure that DexCom is in compliance and well-positioned for future success.
In addition to these practices, DexCom also places a strong emphasis on ethical behavior and transparency. The company has a code of conduct that all employees are expected to follow, and there are clear channels for reporting any concerns or violations. DexCom also regularly communicates with shareholders and other stakeholders about the company’s performance and future plans.
Another important aspect of DexCom’s corporate governance practices is diversity and inclusion. The company is committed to having a diverse board of directors and workforce, and has implemented programs to promote diversity and inclusion at all levels of the organization. This includes unconscious bias training, mentorship programs, and employee resource groups.
The DexCom board of directors recognizes the importance of diversity and inclusion, both in terms of its own composition and in the company as a whole. Board members prioritize diversity in decision-making processes and foster an inclusive environment that values differences in perspective and experience. The board also works to ensure that DexCom’s products and services are inclusive and accessible to all individuals who could benefit from them.
Research has shown that diverse teams are more innovative and effective in problem-solving. By prioritizing diversity and inclusion on the board of directors, DexCom is able to tap into a wider range of perspectives and experiences, leading to better decision-making and ultimately, better outcomes for the company and its stakeholders.
In addition, by ensuring that DexCom’s products and services are inclusive and accessible to all individuals, the company is able to better serve its diverse customer base. This not only benefits the individuals who use DexCom’s products, but also helps to build brand loyalty and trust among a wider range of consumers.
The key responsibilities and duties of a director on the DexCom board include taking an active role in decision-making processes, representing the interests of shareholders, and providing strategic oversight to management. Directors are also responsible for maintaining a high level of integrity and ethical behavior, and for ensuring that the company is in compliance with all relevant regulations and policies.
Additionally, directors on the DexCom board are expected to stay informed about industry trends and developments, and to bring their expertise and knowledge to the boardroom discussions. They are also responsible for evaluating the performance of the CEO and other top executives, and for making decisions about executive compensation and succession planning. Overall, the role of a director on the DexCom board is critical to the success of the company and requires a strong commitment to excellence and accountability.
The board of directors ensures accountability and transparency at DexCom by promoting open communication among board members, management, shareholders, and other stakeholders. The board also holds regular meetings to discuss the company’s progress and goals, and to address any issues or concerns that may arise. Additionally, the board ensures that financial reporting and other disclosures are accurate and transparent, and that the company’s operations are conducted with the highest level of integrity and ethical behavior.
Shareholders play an important role in electing and appointing members to the DexCom board of directors. Each year, shareholders are given the opportunity to vote on director nominees. Shareholders can also bring concerns or recommendations to the attention of the board through various channels, such as the company’s website or annual meeting. This input is taken into consideration when the board is making decisions.
The future direction of DexCom under its current board leadership is focused on continuing to develop innovative products and services that improve the lives of individuals with diabetes. The board recognizes the potential for growth in the continuous glucose monitoring market, and is committed to maintaining DexCom’s position as a leader in the industry. The board is also focused on expanding access to its products and services, and growing the company’s presence in international markets.
The composition and functioning of the DexCom board of directors has evolved over time to reflect the changing needs of the company. As the company has grown and expanded its product offerings, the board has added members with relevant experience and expertise. Additionally, the board has become more focused on corporate governance practices and has taken on a greater role in shaping the company’s vision and strategy.
Overall, the DexCom board of directors is a group of passionate and dedicated individuals who are committed to making a difference in the lives of individuals with diabetes. Their expertise, diversity, and commitment to transparency and ethical behavior make them a valuable asset to the company and its stakeholders.
Join an Advisory Board
Companies are looking for executives just like you.
See what you qualify for with our 2-minute assessment